2m 2m 2m 2m 2m 2m 2m
United Hlth Prod (UEEC)
OTC
$0.06+$0.003 (+5.82%)
Price as of Jun 03, 2026- $16.4MMarket Cap
- -68.07%1-Year Change
- Medical Instruments & SuppliesIndustry
United Hlth Prod (UEEC)
$0.06+$0.003 (+5.82%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 N/A | 0 -100.00% | 37,500 +63,459.32% | |
Cost of Revenue | N/A N/A | N/A N/A | 0 -100.00% | 18,644 +74,476.00% | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 18,856 +55,358.82% | |
Sales and Marketing Expense | 2.0M +20.22% | 1.7M -9.63% | 1.8M -16.78% | 2.2M -92.57% | |
Research and Development Expense | -269,867 -24.18% | -355,936 -40.56% | -598,810 -4.12% | -624,564 +163.02% | |
Depreciation and Amortization Expense | 4,050 0.00% | 4,050 0.00% | 4,050 N/A | N/A N/A | |
Total Operating Expenses | 2.3M +12.35% | 2.0M -17.27% | 2.4M -13.98% | 2.8M -90.53% | |
Operating Profit | -2.3M +12.35% | -2.0M -17.27% | -2.4M -13.40% | -2.8M -90.60% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -113,284 +250.49% | -32,322 -20.22% | -40,512 +138.00% | -17,022 -92.47% | |
Interest Income and Expense and Net | -113,284 +250.49% | -32,322 -20.22% | -40,512 +138.00% | -17,022 -92.47% | |
Total Nonoperating Income and Expense | -413,874 -7,188.10% | 5,839 +102.97% | -196,728 -117.65% | 1.1M +248.89% | |
Income before Taxes | -2.3M +12.35% | -2.0M -17.27% | -2.4M -13.40% | -2.8M -90.60% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -2.7M +33.35% | -2.0M -23.69% | -2.6M +55.45% | -1.7M -94.48% | |
Net Income from Continuing Operations Applicable to Common | -2.7M +33.35% | -2.0M -23.69% | -2.6M +55.45% | -1.7M -94.48% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.01 0.00% | -0.01 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 257.0M +3.55% | 248.2M +3.80% | 239.1M +4.08% | 229.7M N/A | |
Diluted Weighted Average Shares | 257.0M +3.55% | 248.2M +3.80% | 239.1M +4.08% | 229.7M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 65,249 -61.36% | 168,883 +76.99% | 95,420 +613.31% | 13,377 -38.63% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 65,249 -61.36% | 168,883 +76.99% | 95,420 +613.31% | 13,377 -38.63% | |
Total Current Assets | 105,392 -45.02% | 191,683 +26.26% | 151,822 +113.72% | 71,039 +165.08% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 169,582 N/A | 0 -100.00% | 21,051 -91.34% | 243,039 N/A | |
Total Assets | 316,698 +17.30% | 269,979 -5.15% | 284,643 -18.80% | 350,528 +1,207.99% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 500,000 N/A | 0 -100.00% | 207,500 -44.33% | 372,756 +70.21% | |
Total Current Liabilities | 3.9M +140.27% | 1.6M -15.85% | 2.0M -19.25% | 2.4M +106.68% | |
Total Long-Term Debt | 0 -100.00% | 557,500 N/A | 0 -100.00% | 9,136 N/A | |
Total Long-Term Liabilities | 141,248 +831.84% | 15,158 -68.74% | 48,489 -80.05% | 243,039 N/A | |
Total Liabilities | 4.2M +54.51% | 2.7M +35.77% | 2.0M -17.25% | 2.4M +106.68% | |
Retained Earnings | -81.4M +3.39% | -78.7M +2.61% | -76.7M +3.54% | -74.1M +2.33% | |
Total Stockholders Equity | -3.9M +58.62% | -2.4M +42.56% | -1.7M -16.98% | -2.1M +80.83% | |
Total Shares Outstanding | 258.7M +2.49% | 252.4M +3.12% | 244.8M +6.03% | 230.9M +0.96% | |
Cash Flow | |||||
Cash from Operating Activities | -1.2M -0.65% | -1.2M -45.71% | -2.2M +255.10% | -619,720 -25.16% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 0 N/A | 0 +100.00% | -2,850 -92.96% | -40,500 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.1M -14.58% | 1.3M -44.51% | 2.3M +250.65% | 651,798 -18.91% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 50.28% -12.74% | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -7,472.10% -99.99% | |
Return on Assets | -909.99% +26.07% | -721.84% -12.61% | -826.00% -7.65% | -894.45% -96.43% | |
Return on Equity | 84.47% -12.27% | 96.28% -30.65% | 138.83% +31.91% | 105.24% -96.39% | |
Revenue Growth | N/A N/A | N/A N/A | -100.00% -100.16% | 63,459.32% +69,970.42% | |
Current Ratio | 0.03 -77.14% | 0.12 +50.13% | 0.08 +164.63% | 0.03 +28.38% | |
Cash Ratio | 0.02 -83.97% | 0.10 +110.43% | 0.05 +789.09% | 0.006 -70.59% | |
Debt-to-Equity Ratio | -0.13 -43.45% | -0.23 +88.51% | -0.12 -34.56% | -0.18 -3.60% | |
Debt-to-Assets Ratio | 1.58 -23.54% | 2.07 +183.26% | 0.73 -33.09% | 1.09 -86.67% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow